This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Spectranetics TightRail(TM) Rotating Dilator Sheath Achieves Clinical Goal In First In-patient Case

Stocks in this article: SPNC

COLORADO SPRINGS, Colo., May 7, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) announced successful completion of the first live case using the TightRailâ„¢ Rotating Dilator Sheath performed by Charles Love, MD. On the heels of FDA clearance in April, the procedure represents a significant milestone as the company readies the TightRail tool for full launch later this month.

"I was very pleased with how TightRail handled and tracked through the vasculature," said Dr. Love. "It easily passed through occlusions in the chronically occluded innominate vein and superior vena cava. These included areas that had some calcification. We easily and safely achieved the clinical goal. TightRail had no effect on the non-targeted leads in our experience."

Dr. Love also accomplished one of the first lead extraction cases in the United State using the SightRailâ„¢ Manual Dilator Sheath. SightRail and TightRail represent Spectranetics' expansion of its portfolio to include manual extraction tools that complement the company's laser-based technology and provide a broader range of options for extracting physicians.

According to Dr. Love, the additional inner sheath offset length that SightRail offers was especially helpful during the procedure. SightRail is also differentiated by visual indicators that show bevel orientation and tip alignment, supplementing fluoroscopy as a means of determining position and orientation.

When Heart Rhythm Society's 35th Scientific Sessions convene in San Francisco this week, Dr. Love will present his first-case experiences and discuss next-generation mechanical extraction tools. His presentation is scheduled for Thursday, May 8, 9:45 a.m. in Spectranetics' Booth 2202. About Spectranetics

Spectranetics develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The company's products are sold in more than 40 countries and are used to access and treat arterial blockages in the legs and heart, and to remove pacemaker and defibrillator cardiac leads.

1 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs